Dapagliflozin (10mg), Vildagliptin SR (100mg)

May 20, 2023

Dapagliflozin (10mg), Vildagliptin SR (100mg)
DAPA VILDA
Dapagliflozin is a medication classified as a sodium-glucose co-transporter 2 (SGLT2) inhibitor. It works by blocking the reabsorption of glucose in the kidneys, leading to increased urinary glucose excretion. This mechanism helps lower blood sugar levels by removing excess glucose from the body through urine. Dapagliflozin is usually taken once daily in tablet form and is often used in combination with other antidiabetic medications.
Vildagliptin is a medication classified as a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by inhibiting the enzyme DPP-4, which breaks down incretin hormones like GLP-1 (glucagon-like peptide 1). By inhibiting DPP-4, vildagliptin increases the levels of GLP-1, which stimulates the release of insulin and reduces the production of glucagon, a hormone that raises blood sugar levels. The "SR" in Vildagliptin SR stands for "sustained release," indicating that it is formulated to release the medication gradually over time. Vildagliptin SR is usually taken once daily.
STERIS PHARMA Generic medicines undergo rigorous regulatory review to ensure their safety, quality, and effectiveness. Generic medicines are significantly cheaper than their brand-name counterparts. Generic medicines are required to meet the same strict quality standards as brand-name drugs.
For further information please contact:
contact@sterispharma.com
Order now - https://www.sterisonline.com/product/dapa-vilda-10-100-sr-134064

SHARE WITH